IVD technology innovation favored by capital

Recently, CFDA released the 2015 annual medical device registration report. According to the report, 7530 medical device registrations were approved in 2015, of which 2707 were in vitro diagnostic reagents, accounting for 35.9. From the first and continuation of the registration data, in vitro diagnostic reagents in the corresponding registration of the product ratio occupies a clear advantage.

IVD favored by capital

"Due to the influence of R & D and policies, the growth of the pharmaceutical market has slowed down in recent years, while the growth rate of the medical device field, especially the in vitro diagnostic (IVD) field, has reached about 20%." An expert familiar with the IVD field predicts that China's in vitro diagnostic market will continue to maintain double-digit growth in the next few years. "As one of the representatives of emerging industries and sunrise industries, the domestic in vitro diagnostic market is in a period of rapid growth and has huge development. space."

In the past two years, IVD industry mergers and acquisitions, investment is quite hot, many companies have been involved. From the perspective of long-term investment in the industry, the future growth and integration of IVD space is also very large.

"The characteristics of China's IVD market are very obvious. First, the 50 billion yuan market accommodates nearly 1000 companies, and there is still some room for development in this scale; second, the entire market development is led by technology." Qian Jing, director of Fangyuan Capital, said that in vitro diagnostics is one of the core areas of investment, regardless of market size, market growth rate or market pattern.

Dr. Hua Ping, managing partner of Softbank China Capital, expressed a similar view: "IVD has always been the focus of our investment, and it is also a market segment that we pay special attention to in the field of medical investment. We invested in in vitro diagnostic reagent companies in 2007, and later 50 companies. From early products to later services, we have been investing along the development of IVD industry. There are many innovations in this industry, especially technological innovation."

technology innovation

As the in vitro diagnostics industry becomes more and more hot, some international giants have accelerated the speed of product innovation. At the 75th China International Medical Device (Spring) Expo and the 22nd China International Medical Device Design and Manufacturing Technology (Spring) Exhibition held not long ago, Abbott officially released a new MultiSR fully automatic chemiluminescence workstation.

Lin Risheng, vice president of Abbott's diagnostic business department and general manager of China, said: "the purchase of automated assembly lines suitable for their own laboratories is a problem that laboratory managers have been studying and discussing. According to the needs of customers in China's immune laboratory, Abbott China's clinical diagnosis department has set up a professional process design team, TSD team, which has specially customized China's first MultiSR full-automatic chemiluminescence workstation with an hourly flux of more than 800 speeds to help the laboratory analyze the crux of the current process and give suggestions for workflow analysis so that the laboratory can choose its own automation solution according to the site, personnel, budget and expected results."

It is understood that China's inspection equipment market has become more and more unique in identifying and commenting on fully automated assembly lines. From the early emphasis on visual shock and the pursuit of results, the installation of the whole laboratory automation system, to the gradual objective, the ability to judge the real benefits of the assembly line, choose their own laboratory scale of automated work units or offline automation solutions.

In this regard, some experts pointed out that the fully automatic luminous workstation can help the laboratory to achieve more simplified on-board reagent management, and improve efficiency output, and optimize the daily work of laboratory operators.